Dc Funds, LP

Investment Portfolio & 13F Holdings Analysis

About

DC Funds, LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 3 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 3
Total Value: 2066797
Accession Number: 0001398344-25-009329
Form Type: 13F-HR
CIK: 0001869028
Manager Name: Dc Funds, LP

Data Enrichment

100% identified

3 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

3 positions • $2,066.797K total value

3 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

TScan Therapeutics, Inc.

TCRX|89854M101

630000(+0.0%)

Value:

$869.4M(-54.6%)

Barinthus Biotherapeutics plc.

BRNS|91864C107

642204(+0.0%)

Value:

$624.7M(-19.5%)

Werewolf Therapeutics, Inc.

HOWL|95075A107

589102(+0.0%)

Value:

$572.7M(-34.3%)

Instrument	Shares		Other Manager	Value
Tscan Therapeutics, Inc.(TCRXcusip89854M101)	630.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$869.4K	QoQ -54.60% (-$1.0M) YoY -82.61% (-$4.1M)
Barinthus Biotherapeutics Plc.(BRNScusip91864C107)	642.2K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$624.7K	QoQ -19.47% (-$151.1K) YoY -59.13% (-$903.8K)
Werewolf Therapeutics, Inc.(HOWLcusip95075A107)	589.1K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$572.7K	QoQ -34.31% (-$299.1K) YoY -84.99% (-$3.2M)